Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
Clin Lymphoma Myeloma Leuk ; 21(1): e66-e75, 2021 01.
Article in English | MEDLINE | ID: covidwho-718689

ABSTRACT

Histiocytic disorders are an exceptionally rare group of diseases with diverse manifestations and a paucity of approved treatments, thereby leading to various challenges in their diagnosis and management. With the discovery of novel molecular targets and the incorporation of targeted agents in the management of various adult histiocytic disorders, their management has become increasingly complex. In an attempt to improve the understanding of the clinical features and management of common adult histiocytic disorders (Langerhans cell histiocytosis, Erdheim-Chester disease, Rosai-Dorfman disease, and hemophagocytic lymphohistiocytosis), we created this document based on existing literature and expert opinion.


Subject(s)
Erdheim-Chester Disease/drug therapy , Histiocytosis, Langerhans-Cell/drug therapy , Histiocytosis, Sinus/drug therapy , Lymphohistiocytosis, Hemophagocytic/drug therapy , Adult , Drug Therapy, Combination , Erdheim-Chester Disease/diagnosis , Histiocytosis, Langerhans-Cell/diagnosis , Histiocytosis, Sinus/diagnosis , Humans , Lymphohistiocytosis, Hemophagocytic/diagnosis , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL